期刊
SAUDI PHARMACEUTICAL JOURNAL
卷 29, 期 5, 页码 434-445出版社
ELSEVIER
DOI: 10.1016/j.jsps.2021.04.004
关键词
Anthelmintics; Antiparasitic; Cancer; Drug repositioning; Solubility
Drug repositioning is a critical process to identify new applications for existing drugs, which can reduce the chance of failure, lower development costs, and shorten approval times. Anthelmintics, known for their antiparasitic properties, have shown promising anticancer effects, suggesting potential for cancer therapy.
Drug repositioning is defined as a process to identify a new application for drugs. This approach is critical as it takes advantage of well-known pharmacokinetics, pharmacodynamics, and toxicity profiles of the drugs; thus, the chance of their future failure decreases, and the cost of their development and the required time for their approval are reduced. Anthelmintics, which are antiparasitic drugs, have recently demonstrated promising anticancer effects in vitro and in vivo. This literature review focuses on the potential of anthelmintics for repositioning in the treatment of cancers. It also discusses their pharmacokinetics and pharmacodynamics as antiparasitic drugs, proposed anticancer mechanisms, present development conditions, challenges in cancer therapy, and strategies to overcome these challenges. (c) 2021 The Authors. Published by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据